Literature DB >> 29136261

Decrease in Diversity of Propionibacterium acnes Phylotypes in Patients with Severe Acne on the Back.

Marie-Ange Dagnelie1, Stéphane Corvec, Mélanie Saint-Jean, Valérie Bourdès, Jean-Michel Nguyen, Amir Khammari, Brigitte Dréno.   

Abstract

Propionibacterium acnes, a major member of normal skin microbiota, is subdivided into 6 phylotypes: IA1, IA2, IB, IC, II and III. This study investigated P. acnes subgroups on the face and back in patients with severe acne and in healthy controls. In 71.4% of patients with severe acne, P. acnes phylotypes were identical on the face and back, whereas this was the case in only 45.5% of healthy controls. The healthy group carried phylotypes IA1 (39.1%) and II (43.4%), whereas the acne group carried a high predominance of IA1 (84.4%), especially on the back (95.6%). In addition, the single-locus sequence typing (SLST) method revealed A1 to be the predominant type on the back of patients with acne, compared with a wide diversity in the healthy group. We report here that severity of acne on the back is associated with loss of diversity of P. acnes phylotype, with a major predominance of phylotype IA1. The change in balance of cutaneous P. acnes subgroups might be an inducing factor in the activation of P. acnes, which could trigger inflammation.

Entities:  

Mesh:

Year:  2018        PMID: 29136261     DOI: 10.2340/00015555-2847

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  13 in total

1.  Structural and biochemical characterization of the Cutibacterium acnes exo-β-1,4-mannosidase that targets the N-glycan core of host glycoproteins.

Authors:  Tom Reichenbach; Dayanand Kalyani; Rosaria Gandini; Olov Svartström; Henrik Aspeborg; Christina Divne
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

2.  Cutibacterium acnes Phylotype I and II Strains Interact Differently With Human Skin Cells.

Authors:  Karl-Jan Spittaels; Ruben Ongena; Christos C Zouboulis; Aurélie Crabbé; Tom Coenye
Journal:  Front Cell Infect Microbiol       Date:  2020-11-16       Impact factor: 5.293

3.  Prepubertal acne: A retrospective study.

Authors:  Cécile Frénard; Siham Mansouri; Stéphane Corvec; Aurélie Boisrobert; Amir Khammari; Brigitte Dréno
Journal:  Int J Womens Dermatol       Date:  2021-04-07

4.  Solution Structure of the Cutibacterium acnes-Specific Protein RoxP and Insights Into Its Antioxidant Activity.

Authors:  Kristian Stødkilde; Jakob Toudahl Nielsen; Steen Vang Petersen; Bernhard Paetzold; Holger Brüggemann; Frans A A Mulder; Christian Brix Folsted Andersen
Journal:  Front Cell Infect Microbiol       Date:  2022-02-11       Impact factor: 5.293

Review 5.  Truncal Acne: An Overview.

Authors:  Yu Ri Woo; Hei Sung Kim
Journal:  J Clin Med       Date:  2022-06-24       Impact factor: 4.964

Review 6.  The Human Skin Microbiome in Selected Cutaneous Diseases.

Authors:  Silvia Carmona-Cruz; Luz Orozco-Covarrubias; Marimar Sáez-de-Ocariz
Journal:  Front Cell Infect Microbiol       Date:  2022-03-07       Impact factor: 5.293

7.  Alteration in the Skin Microbiome in Cutaneous Graft Versus Host Disease.

Authors:  Ying Gu; Jing Sun; Kun Li; Xia Wu; Jianzhong Zhang
Journal:  Acta Derm Venereol       Date:  2021-01-20       Impact factor: 3.875

Review 8.  Staphylococcus epidermidis and Cutibacterium acnes: Two Major Sentinels of Skin Microbiota and the Influence of Cosmetics.

Authors:  Mathilde Fournière; Thomas Latire; Djouhar Souak; Marc G J Feuilloley; Gilles Bedoux
Journal:  Microorganisms       Date:  2020-11-07

Review 9.  From Dysbiosis to Healthy Skin: Major Contributions of Cutibacterium acnes to Skin Homeostasis.

Authors:  Miquel Rozas; Astrid Hart de Ruijter; Maria Jose Fabrega; Amine Zorgani; Marc Guell; Bernhard Paetzold; Francois Brillet
Journal:  Microorganisms       Date:  2021-03-18

Review 10.  A Janus-Faced Bacterium: Host-Beneficial and -Detrimental Roles of Cutibacterium acnes.

Authors:  Holger Brüggemann; Llanos Salar-Vidal; Harald P M Gollnick; Rolf Lood
Journal:  Front Microbiol       Date:  2021-05-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.